Product catalog antigen listed by alphabetic starting with L
| Items 201 to 300 of 496 total | 5 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00163175-Q01-10 | LGI4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00163175-Q01-25 | LGI4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00005641-P01-10 | LGMN antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00005641-P01-25 | LGMN antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084514-Q01-10 | LGP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084514-Q01-25 | LGP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003975-Q01-10 | LHX1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003975-Q01-25 | LHX1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009355-Q01-10 | LHX2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009355-Q01-25 | LHX2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008022-Q01-10 | LHX3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008022-Q01-25 | LHX3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00089884-Q01-10 | LHX4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00089884-Q01-25 | LHX4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064211-Q01-10 | LHX5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064211-Q01-25 | LHX5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026468-Q01-10 | LHX6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026468-Q01-25 | LHX6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056956-Q01-10 | LHX9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056956-Q01-25 | LHX9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011019-Q01-10 | LIAS antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011019-Q01-25 | LIAS antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003977-Q01-10 | LIFR antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003977-Q01-25 | LIFR antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003978-Q01-10 | LIG1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003978-Q01-25 | LIG1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003980-Q01-10 | LIG3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003980-Q01-25 | LIG3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003981-Q01-10 | LIG4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003981-Q01-25 | LIG4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA192 | LIGHT antigen | ||||||
| Mouse | Purified | >95% | E. coli | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| PA192X | LIGHT antigen | ||||||
| Mouse | Purified | >95% | E. coli | 20 µg / US$ 355 | |||
| Acris Antibodies GmbH | |||||||
| H00010859-P01-10 | LILRA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010859-P01-25 | LILRA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011027-Q01-10 | LILRA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011027-Q01-25 | LILRA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011026-P01-02 | LILRA3 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011026-P01-10 | LILRA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011026-P01-25 | LILRA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006323-P01-10 | LILRB1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006323-P01-25 | LILRB1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010288-P01-10 | LILRB2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010288-P01-25 | LILRB2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011006-P01-10 | LILRB4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011006-P01-25 | LILRB4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010990-P01-10 | LILRB5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010990-P01-25 | LILRB5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22068F | LIM and cysteine-rich domains protein 1 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22068F-50 | LIM and cysteine-rich domains protein 1 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22104F | LIM domain transcription factor LMO4 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22104F-50 | LIM domain transcription factor LMO4 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00051474-P01-10 | LIMA1 / EPLIN antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051474-P01-25 | LIMA1 / EPLIN antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PBL12295-1 | Limitin antigen | ||||||
| Human | > 95% | E. coli | 50 µg / --- | ||||
| PBL Biomedical Laboratories | |||||||
| H00003984-P01-10 | LIMK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003984-P01-25 | LIMK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003984-Q01-10 | LIMK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003984-Q01-25 | LIMK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003985-P01-10 | LIMK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003985-Q01-10 | LIMK2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003985-Q01-25 | LIMK2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA1091 | Limulus Antilipopolysaccharide Factor (LALF) antigen | ||||||
| Limulus | Purified | >95% | Pichia pastoris | 0.1 mg / US$ 635 | |||
| Acris Antibodies GmbH | |||||||
| PA1299 | Limulus Antilipopolysaccharide Factor (LALF) antigen | ||||||
| Limulus | Purified | >95% | Pichia pastoris | 20 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1299X | Limulus Antilipopolysaccharide Factor (LALF) antigen | ||||||
| Limulus | Purified | >95% | Pichia pastoris | 0.1 mg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1299XC | Limulus Antilipopolysaccharide Factor (LALF) antigen | ||||||
| Limulus | Purified | >95% | Pichia pastoris | 0.5 mg / US$ 485 | |||
| Acris Antibodies GmbH | |||||||
| H00003988-P01-10 | LIPA antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003988-P01-25 | LIPA antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008513-Q01-10 | LIPF antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008513-Q01-25 | LIPF antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA023 | Lipopolysaccharide-induced CXC chemokine (LIX) antigen | ||||||
| Mouse | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA023X | Lipopolysaccharide-induced CXC chemokine (LIX) antigen | ||||||
| Mouse | >98% | E. coli | 20 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| BA399 | Lipoprotein (a) (Lp (a)) antigen | ||||||
| Human | Purified | >99% | Plasma | 0.1 mg / US$ 495 | |||
| Acris Antibodies GmbH | |||||||
| BA400HS | Lipoprotein High Density (HDL) antigen | ||||||
| Human | Purified | >95% | Plasma | 1 mg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| BA1089 | Lipoprotein High Density (HDL) 2 Subfraction antigen | ||||||
| Human | Purified | - | Plasma | 1 mg / US$ 425 | |||
| Acris Antibodies GmbH | |||||||
| BA400LS | Lipoprotein Low Density (Narrow) (LDL) antigen | ||||||
| Human | Purified | >95% | Plasma | 1 mg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| AR00115PU-N | Lipoprotein, Very Low Density (VLDL) antigen | ||||||
| Human | Purified | Plasma | 1 mg / US$ 325 | ||||
| Acris Antibodies GmbH | |||||||
| PA1331 | Listeriolysin-O antigen | ||||||
| L. monocytogenes | Purified | >90% | E. coli | 10 µg / US$ 325 | |||
| Acris Antibodies GmbH | |||||||
| PA1331X | Listeriolysin-O antigen | ||||||
| L. monocytogenes | Purified | >90% | E. coli | 50 µg / US$ 585 | |||
| Acris Antibodies GmbH | |||||||
| PA1331XC | Listeriolysin-O antigen | ||||||
| L. monocytogenes | Purified | >90% | E. coli | 0.1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| 10-288-22380F | Lithostathine 1 alpha antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22380F-50 | Lithostathine 1 alpha antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| PA1352 | Lithostathine 1 alpha (REG1A) antigen | ||||||
| Human | Purified | >95% | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1352X | Lithostathine 1 alpha (REG1A) antigen | ||||||
| Human | Purified | >90% | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1352XC | Lithostathine 1 alpha (REG1A) antigen | ||||||
| Human | Purified | >90% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| AR03006PU-L | Livin (BIRC7) (aa1-298) antigen | ||||||
| Human | Purified | >90% | E. coli | 0.5 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| AR03006PU-N | Livin (BIRC7) (aa1-298) antigen | ||||||
| Human | Purified | >90% | E. coli | 0.1 mg / US$ 455 | |||
| Acris Antibodies GmbH | |||||||
| GTX26234 | Livin peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29985 | LIX protein antigen | ||||||
| 20 µg / --- | |||||||
| GeneTex Inc. | |||||||
| P283-5 | LKM 1 Antigen | ||||||
| Human | Purified | >90% | Insect cells | 0.1 mg / ask | |||
| Scipac Ltd. | |||||||
| H00003993-Q01-10 | LLGL2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003993-Q01-25 | LLGL2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029995-Q01-10 | LMCD1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029995-Q01-25 | LMCD1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004004-Q01-10 | LMO1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004004-Q01-25 | LMO1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004005-P01-10 | LMO2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004005-P01-25 | LMO2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055885-P01-02 | LMO3 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055885-P01-10 | LMO3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055885-P01-25 | LMO3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008543-P01-10 | LMO4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 201 to 300 of 496 total | 5 Page(s): |



